Completion of Placing

Huveaux PLC
04 September 2006


4 September 2006


                                  HUVEAUX PLC

 Completion of the Placing of 11,827,957 new ordinary shares at 46.5 pence per
                          share to raise £5.5 million


Further to today's earlier announcement of the acquisition of Letts and Leckie,
the Board of Huveaux PLC ('Huveaux') announces that it has completed the Placing
of 11,827,957 new ordinary shares (the 'New Ordinary Shares') at a price of 46.5
pence per share to institutional investors, raising £5.5 million.


For further information, please contact:


Huveaux                                                            020 7245 0270

John van Kuffeler, Executive Chairman

Gerry Murray, Chief Executive Officer

Dan O'Brien, Group Finance Director


Dresdner Kleinwort                                                 020 7623 8000

Charles Batten

Joe Thompson


Bell Lawrie                                                        0141 314 8108

Iain Macarthur


Finsbury                                                           020 7251 3801

James Leviton

This announcement has been prepared solely to provide information about the 
Placing and it does not constitute, or form part of, any offer or invitation to 
purchase, underwrite or otherwise acquire New Ordinary Shares being offered, or 
the solicitation of any such offer. Without limiting the foregoing statement, 
this announcement does not constitute an offer of securities for sale in the 
United States nor the solicitation of an offer to buy any such securities, nor 
may securities be offered or sold in the United States absent registration or an
exemption from registration as provided in the United States Securities Act of 
1933, as amended (the 'Securities Act'), and the rules and regulations 
thereunder. Huveaux does not intend to register the New Ordinary Shares under 
the Securities Act.

This announcement does not constitute an offer to sell or issue or a 
solicitation of an offer to buy or subscribe for New Ordinary Shares in any 
jurisdiction including, without limitation, Canada, Australia, Japan or any 
other jurisdiction in which such offer or solicitation is or may be unlawful.
This announcement and the information contained herein are not for publication 
or distribution, directly or indirectly, to persons in Canada, Australia or 
Japan unless permitted pursuant to an exemption under the relevant local law or
in any jurisdiction in which such publication or distribution is unlawful.

Dresdner Kleinwort Wasserstein Limited and Dresdner Bank AG, London Branch, 
which are authorised and regulated by the Financial Services Authority, are 
acting for Huveaux and for no one else in connection with the Placing and will 
not be responsible to anyone other than Huveaux for providing the protections 
afforded to the customers of Dresdner Kleinwort Wasserstein Limited and Dresdner
Bank AG, London Branch or for affording advice in relation to the Placing, or 
any other matters referred to herein.

This statement should not be interpreted to mean that future earnings per share 
of Huveaux will necessarily be greater than those of previous periods.

No representation or warranty, express or implied, is made by Dresdner Kleinwort
as to any of the contents of this announcement for which the directors of 
Huveaux are solely responsible. This announcement contains certain 
forward-looking statements. Such forward-looking statements are based on current
plans, information and intentions and certain external factors which may be 
beyond the control of Huveaux, and therefore, undue reliance should not be 
placed on them. Such forward-looking statements involve unknown risks, 
uncertainties and other factors which may cause the actual results, financial 
condition, performance or achievements of Huveaux, or industry results, to be 
materially different from any future results, performance or achievements 
expressed or implied by such forward-looking statements. Forward-looking 
statements speak only as to the date on which they are made and Huveaux 
undertakes no obligation to update publicly any such forward-looking statements 
in this announcement to reflect future events or developments.

Note to Editors:


   • Huveaux

Huveaux was formed in 2001 with the objective of building a substantial,
high-quality publishing and media group. It is now twenty fold the size when it
first listed on AIM.

The Group consists of three Divisions each of which has strong brands and
market-leading positions:


Political Division comprises Dod's Parliamentary Companion, The House Magazine,
Epolitix.com, Political Wizard and numerous other magazine titles and
revenue-generating websites. It is the market leader in Political
business-to-business publishing in the UK and the EU.


Learning Division comprises Epic, the UK market leader in e-learning; The
Training Journal magazine and seminar business; Lonsdale Revision Guides for
schools and the highly acclaimed Westminster Explained conferences and seminars.


Healthcare Division based in France, comprises Panorama du Medecin, a leading
weekly magazine for French doctors; Le Concours Medical and La Revue du
Praticien, both market-leading Continuing Medical Education magazines; Egora.fr,
the leading medical information website; and a number of other magazines and a
medical conference business.


Huveaux has now completed ten successful acquisitions over the past four years
and employs more than 450 staff in London, Paris, Brussels and four UK regional
offices.


Further information about Huveaux can be found at www.huveauxplc.com


The name Huveaux is a trademark of Huveaux PLC. All other trademarks mentioned
herein are the property of Huveaux's respective subsidiary companies. All rights
reserved.


                      This information is provided by RNS
            The company news service from the London Stock Exchange